Biosplice Therapeutics is based in San Diego. It has raised $778M in total funding. Latest round: Series E.
Biosplice Therapeutics is based in San Diego. Biosplice Therapeutics has raised $778M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in April 2021. The round record for Biosplice Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include SymBiosis Capital Management, Eventide Funds, aMoon, Polar Light Ventures, Ingka Investments, Vickers Venture Partners and 1 others. 7 distinct backers are named across the disclosed rounds.
Every Biosplice Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026